Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.36 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.34 |
| ▸ | METAP2 | P50579 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21927655 | 0.91 | ALDH1A1 (0.38) | ALDH1A1HTTHSD17B10KMT2AMEN1 | |
| SCHEMBL21929618 | 0.89 | KMT2A (0.40) | ALDH1A1HTTHSD17B10KMT2AMEN1 | |
| SCHEMBL21927957 | 0.85 | ALDH1A1 (0.35) | ALDH1A1HTTHSD17B10KMT2AMEN1 | |
| SCHEMBL21927945 | 0.84 | ALDH1A1 (0.43) | ALDH1A1HTTHSD17B10KMT2AMEN1 | |
| SCHEMBL21929619 | 0.83 | ALDH1A1 (0.44) | ALDH1A1HTTHSD17B10KMT2AMEN1 | |
| SCHEMBL21927187 | 0.83 | PRMT5 (0.36) | ALDH1A1HTTHSD17B10KMT2AMEN1 | |
| SCHEMBL21928466 | 0.82 | ALDH1A1 (0.40) | ALDH1A1HTTHSD17B10PRMT5WDR77 | |
| SCHEMBL21927346 | 0.81 | PRMT5 (0.35) | ALDH1A1HTTHSD17B10KMT2AMEN1 | |
| SCHEMBL28367159 | 0.80 | LMNA (0.42) | ALDH1A1KMT2AMEN1MGLLSMN1; SMN2 | |
| SCHEMBL21929624 | 0.80 | HTT (0.41) | ALDH1A1HTTHSD17B10KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200131150-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200131150-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CCNT1, CCNA1, CCNE2 | ALDH1A1 511/4885HTT 2197/4885HSD17B10 3516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.